Literature DB >> 7506157

Antioxidant activity of nimesulide and its main metabolites.

R M Facino1, M Carini, G Aldini.   

Abstract

The antioxidant activity of nimesulide and its main metabolites, 4'-hydroxynimesulide (M1) and 2-(4'-hydroxyphenoxy)-4-N-acetylamino-methansulfonanilide (M2), was investigated using 2 in vitro models: NADPH-supported lipid peroxidation in rat liver microsomes (marker MDA formation) and xanthine/xanthine oxidase, iron-promoted depolymerisation of hyaluronic acid, determined by gel permeation chromatographic analysis (marker molecular weight distribution). In the lipid peroxidation model, all the compounds inhibited MDA formation in a concentration-dependent manner, although with different potencies; the maximum scavenging effect was observed for M1 [50% inhibitory concentration (IC50) = 30 mumol/L; M2 IC50 = 0.5 mmol/L; nimesulide = 0.8 mmol/L]. Nimesulide was more active than its metabolites in preventing OH-induced depolymerisation of hyaluronic acid, with a 50% effective concentration of approximately 230 mumol/L, which was fairly comparable to that of tenoxicam. This protective effect was due to the OH.-entrapping capacity of the drug, which, in the Fenton-driven model, is easily converted, via OH. attack, to M1 and putatively to 2-hydroxy-4-nitro-methansulfonanilide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506157     DOI: 10.2165/00003495-199300461-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  12 in total

1.  Inhibition of neutrophil oxidative metabolism by nimesulide.

Authors:  F Capsoni; E Venegoni; F Minonzio; A M Ongari; V Maresca; C Zanussi
Journal:  Agents Actions       Date:  1987-06

2.  Phytochemical characterization and radical scavenger activity of flavonoids from Helichrysum italicum G. Don (Compositae).

Authors:  R M Facino; M Carini; L Franzoi; O Pirola; E Bosisio
Journal:  Pharmacol Res       Date:  1990 Nov-Dec       Impact factor: 7.658

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Oxidation of tenoxicam by leukocyte peroxidases and H2O2 produces novel products.

Authors:  S Ichihara; H Tomisawa; H Fukazawa; M Tateishi; R Joly; R Heintz
Journal:  Drug Metab Dispos       Date:  1989 Jul-Aug       Impact factor: 3.922

5.  Involvement of leukocyte peroxidases in the metabolism of tenoxicam.

Authors:  S Ichihara; H Tomisawa; H Fukazawa; M Tateishi
Journal:  Biochem Pharmacol       Date:  1985-04-15       Impact factor: 5.858

Review 6.  Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states.

Authors:  A Ward; R N Brogden
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

7.  Mechanism of action of novel anti-inflammmatory drugs diflumidone and R-805.

Authors:  R L Vigdahl; R H Tukey
Journal:  Biochem Pharmacol       Date:  1977-02-15       Impact factor: 5.858

8.  The amplified chemiluminescence test to characterize antirheumatic drugs as oxygen radical scavengers.

Authors:  R Müller-Peddinghaus; M Wurl
Journal:  Biochem Pharmacol       Date:  1987-04-01       Impact factor: 5.858

9.  Studies on the anti-inflammatory activity of ebselen. Ebselen interferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C?

Authors:  I A Cotgreave; S K Duddy; G E Kass; D Thompson; P Moldéus
Journal:  Biochem Pharmacol       Date:  1989-02-15       Impact factor: 5.858

10.  Effect of metal chelators and antiinflammatory drugs on the degradation of hyaluronic acid.

Authors:  W H Betts; L G Cleland
Journal:  Arthritis Rheum       Date:  1982-12
View more
  9 in total

1.  Detection of nimesulide metabolites in rat plasma and hepatic subcellular fractions by HPLC-UV/DAD and LC-MS/MS studies.

Authors:  S Güniz Küçükgüzel; Ilkay Küçükgüzel; Başak Oral; Sena Sezen; Sevim Rollas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

2.  A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth-muscle cells: role of glucose and 12-hydroxyeicosatetraenoic acid.

Authors:  Evgenia Alpert; Arie Gruzman; Hanan Totary; Nurit Kaiser; Reuven Reich; Shlomo Sasson
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

Review 3.  Nimesulide in dysmenorrhoea.

Authors:  M Pulkkinen
Journal:  Drugs       Date:  1993       Impact factor: 9.546

4.  Indomethacin potentiates acetylcholine-induced vasodilation by increasing free radical production.

Authors:  Antonella De Angelis; Barbara Rinaldi; Annalisa Capuano; Francesco Rossi; Amelia Filippelli
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

5.  An analysis from clinico-epidemiological data of the principal adverse events from the COX-2 selective NSAID, nimesulide, with particular reference to hepatic injury.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

Review 6.  Clinical pharmacokinetics of nimesulide.

Authors:  A Bernareggi
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

Review 7.  Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  R Davis; R N Brogden
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

Review 8.  Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review.

Authors:  Markus Laube; Torsten Kniess; Jens Pietzsch
Journal:  Antioxidants (Basel)       Date:  2016-04-19

9.  Effects of nimesulide on kainate-induced in vitro oxidative damage in rat brain homogenates.

Authors:  Eduardo Candelario-Jalil; Olga Sonia León
Journal:  BMC Pharmacol       Date:  2003-06-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.